Active ingredientVorapaxar SulfateCat. No. P-V060-001CAS 705260-08-8Family · Pharmaceutical analytical standards
Vorapaxar
An antiplatelet drug that blocks the PAR-1 receptor, through which thrombin activates platelets; approved in the United States in 2014 to reduce the risk of cardiovascular events in people who have had a heart attack or have peripheral arterial disease. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is derived from himbacine, an alkaloid of the tropical tree Galbulimima belgraveana, found from Queensland to New Guinea and the Solomon Islands; it has an unusually long half-life, 5 to 13 days.
Go to the active ingredient →Active ingredientVorapaxar SulfateCat. No. P-V060-001CAS 705260-08-8
Isotopically labelledVorapaxar-d5Cat. No. P-V060-002
ImpurityVorapaxar Impurity 1Cat. No. P-V060-003No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.